Sequential Systemic Treatment in Advanced Hepatocellular Carcinoma Is Able to Prolong Median Survival to More than 3 Years in a Selected Real-World Cohort.

von Felden, Johann; Karkmann, Kathrin; Ittrich, Harald; Gil-Ibanez, Ines; Fründt, Thorben; Krause, Jenny; Lohse, Ansgar W; Wege, Henning; Schulze, Kornelius

von Felden, Johann; Karkmann, Kathrin; Ittrich, Harald; Gil-Ibanez, Ines; Fründt, Thorben; Krause, Jenny; Lohse, Ansgar W; Wege, Henning; Schulze, Kornelius.

Afiliação

von Felden J; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Karkmann K; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ittrich H; Department for Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Gil-Ibanez I; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fründt T; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Krause J; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Lohse AW; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Wege H; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Schulze K; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Visc Med ; 37(2): 87-93, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33981749

Palavras-chave

HCC; Immuno-oncology; Immunotherapy; Liver cancer; Targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google